Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
about
Outcomes of anticoagulation therapy in patients with mental health conditions.Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.The impact of age on the epidemiology of atrial fibrillation hospitalizations.Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.Identifying the risks of anticoagulation in patients with substance abuseAlcohol/Substance misuse and treatment nonadherence: fatal attractionAre the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study.Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.
P2860
Q33633124-130E8BCB-126A-4B26-B4AD-F3683E865E20Q33755738-49EE234F-5FEB-42FE-A5AF-DF2B9142C923Q34056113-4894678B-65E1-4B65-9D86-614F61DB5E76Q34245296-BB9D55B8-992C-4FC7-98EC-5E2FA93EBA03Q35016262-C43D1B90-F623-49CD-B60B-6A6C45CDEF83Q35620065-A91F7740-BF9C-489B-8071-3833DDA7A146Q36841254-083B1491-4576-4F2B-BBFA-D7D59ED7602CQ37203620-9D8A6F2D-C4BE-4488-A3F1-33F7CA16248CQ37203897-65BDA118-C30F-45D7-BE24-9654EA599F6DQ37890023-E802EC41-B657-44E3-8475-E8A036293AD5Q38097727-2D012DD3-8379-49CC-BB76-2BD98A0076A5Q38903357-67B24623-8E70-48E8-9139-B30D3C2AC1E1Q47139884-80F53375-F1AD-49E3-9A7E-7281512AB186Q55424098-D4D92ACD-F922-4517-A08D-1E417CCF295C
P2860
Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Psychosocial risk factors for ...... brillation receiving warfarin.
@ast
Psychosocial risk factors for ...... brillation receiving warfarin.
@en
type
label
Psychosocial risk factors for ...... brillation receiving warfarin.
@ast
Psychosocial risk factors for ...... brillation receiving warfarin.
@en
prefLabel
Psychosocial risk factors for ...... brillation receiving warfarin.
@ast
Psychosocial risk factors for ...... brillation receiving warfarin.
@en
P2093
P2860
P1476
Psychosocial risk factors for ...... ibrillation receiving warfarin
@en
P2093
Charles J Moomaw
Daniel P Schauer
Thomas Webb
P2860
P304
P356
10.1111/J.1525-1497.2005.0242.X
P577
2005-12-01T00:00:00Z
P5875
P6179
1033812639